Stocks TelegraphStocks Telegraph
Stock Ideas

CERO Financial Statements and Analysis

NASDAQ : CERO

CERo Therapeutics Holdings, Inc.

$2.31
-0.03-1.28%
At Close 4:00 PM
$2.34
0.03+1.30%
After-Market 07:31 PM

CERO FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

CERO Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-31
reported currencyUSDUSDUSD
calendar year202420242024
periodQ3Q2Q1
revenue000
cost of revenue0293.252K288.161K
gross profit0-293.252K-288.161K
gross profit ratio000
research and development expenses1.774M2.714M1.38M
general and administrative expenses2.628M2.434M2.884M
selling and marketing expenses000
selling general and administrative expenses2.628M2.434M2.884M
other expenses000
operating expenses4.402M5.148M4.264M
cost and expenses4.402M5.148M4.552M
interest income4.418K00
interest expense016.977K9.629K
depreciation and amortization0293.252K288.161K
ebitda-4.402M-2.138M-2.002M
ebitda ratio000
operating income-4.402M-5.148M-4.552M
operating income ratio000
total other income expenses net174.271K2.70M2.252M
income before tax-4.228M-2.449M-2.30M
income before tax ratio000
income tax expense00-1.00
net income-4.228M-2.449M-2.30M
net income ratio000
eps-0.085-0.15-0.16
eps diluted-0.085-0.15-0.16
weighted average shs out49.676M16.199M14.707M
weighted average shs out dil49.676M16.199M14.707M
Graph

CERO Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-31
reported currencyUSDUSDUSD
calendar year202420242024
periodQ3Q2Q1
cash and cash equivalents
short term investments
cash and short term investments
net receivables
inventory
other current assets
total current assets
property plant equipment net
goodwill
intangible assets
goodwill and intangible assets
long term investments
tax assets
other non current assets
total non current assets
other assets
total assets
account payables
short term debt
tax payables
deferred revenue
other current liabilities
total current liabilities
long term debt
deferred revenue non current
deferred tax liabilities non current
other non current liabilities
total non current liabilities
other liabilities
capital lease obligations
total liabilities
preferred stock
common stock
retained earnings
accumulated other comprehensive income loss
other total stockholders equity
total stockholders equity
total equity
total liabilities and stockholders equity
minority interest
total investments
total debt
net debt
Graph

CERO Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-31
reported currencyUSDUSD
calendar year20242024
periodQ2Q1
deferred income tax00
stock based compensation1.40M100.72K
change in working capital841.407K-905.365K
accounts receivables00
inventory00
accounts payables-265.012K-286.487K
other working capital841.407K-618.878K
other non cash items-3.623M-1.30M
net cash provided by operating activities-3.537M-5.08M
investments in property plant and equipment4.000
acquisitions net00
purchases of investments00
sales maturities of investments00
other investing activites00
net cash used for investing activites00
debt repayment-149.34K-388.337K
common stock issued2.74M6.756M
common stock repurchased00
dividends paid00
other financing activites2.591M13.731K
net cash used provided by financing activities2.591M7.158M
effect of forex changes on cash00
net change in cash-946.077K4.496M
cash at end of period4.611M4.593M
cash at beginning of period5.557M96.873K
operating cashflow-3.537M-5.08M
capital expenditure4.000
free cash flow-3.537M-5.08M
Graph

Frequently Asked Questions

How did CERo Therapeutics Holdings, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, CERO generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did CERo Therapeutics Holdings, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. CERo Therapeutics Holdings, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.

Have CERO's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. CERO incurred $4.40M worth of Operating Expenses, while it generated -$4.40M worth of Operating Income.

How much Net Income has CERO posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from CERo Therapeutics Holdings, Inc., the company generated -$4.23M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did CERo Therapeutics Holdings, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to CERo Therapeutics Holdings, Inc. as of the end of the last quarter was -.

What are CERO's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, CERO had Total Net Receivables of -.

In terms of Total Assets and Current Assets, where did CERo Therapeutics Holdings, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of CERO were -, while the Total Assets stand at -.

As of the last quarter, how much Total Debt did CERo Therapeutics Holdings, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of CERO's debt was - at the end of the last quarter.

What were CERO's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, CERO reported total liabilities of -.

How much did CERO's Working Capital change over the last quarter?

Working Capital Change for CERO was $841.41K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

CERO generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. CERO generated -$3.54M of Cash from Operating Activities during its recently reported quarter.

What was CERO's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. CERO reported a -$946.08K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph